Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.21 -0.83 (-16.47%)
As of: Sep 9, 2026 · 3:47 PM EDT

Curanex Pharmaceuticals (CURX) EBIT (QoQ) (2024 - 2025)

Analysis

Curanex Pharmaceuticals (CURX) EBIT (QoQ) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Curanex Pharmaceuticals 5.97 Mn 3.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -225.09%
Sep 30, 2025 -1,549.95%
Dec 31, 2024 -57.96%